Search In this Thesis
   Search In this Thesis  
العنوان
Effects Of The Antibilharzial Drug Praziquantel On Hearing In Bilharzial Patients \
المؤلف
EL-Sawy, Abd EL-hamid Fayez.
هيئة الاعداد
مشرف / Abd EL-hamid Fayez EL-Sawy
مشرف / Mohamed Kamar EL-Sharnoby
مشرف / Yousry Mostafa Saad
مشرف / EL-Sharnoby, Mohamed Kamar,
الموضوع
Ear- Diseases- Diagnosis.
تاريخ النشر
1994.
عدد الصفحات
111 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب
تاريخ الإجازة
1/1/1994
مكان الإجازة
جامعة المنوفية - كلية الطب - Otorhinolaryngology Department
الفهرس
Only 14 pages are availabe for public view

from 132

from 132

Abstract

Bilharziasis, is an endemic parasitic disease which constitute a major public health problem in many countries of the world including Egypt (World health organisation, 1985)15 - 30% of Egyptian population of the 60 million is infested with schistosoma mansoni and schistosoma haematobium (Harrison et al., 1990)Many drugs were used in mass therapy of bilharziasis e.g. antimonial drugs, niridazole, lucanthone, hycanthone oxamniquine, metrifonate and many others.
Praziquantel (biltricid, distocid) is the drug used now in Egypt for treatment of all types of bilharziasis.
The aim of this work is to study and analyse the effect of praziquantel (biltricid, distocid) as a widely used anti bilhazial drug on hearing threshold of bilharzial patients.
The study was conducted on 60 bilharzial patients 36 males and 24 female. Their age ranged from 20 - 40 years.
Each subject was subjected to full history, full clinical examination, E.N.T. examination, laboratory evaluation and audiological evaluation.